B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer
Clinical trial NCT03953833 · COMPLETED
Trial details
- NCT number
- NCT03953833
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2023-01-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.